JP2011503140A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503140A5 JP2011503140A5 JP2010533558A JP2010533558A JP2011503140A5 JP 2011503140 A5 JP2011503140 A5 JP 2011503140A5 JP 2010533558 A JP2010533558 A JP 2010533558A JP 2010533558 A JP2010533558 A JP 2010533558A JP 2011503140 A5 JP2011503140 A5 JP 2011503140A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- paste according
- paste
- anthelmintic
- thickening agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000507 anthelmentic effect Effects 0.000 claims 6
- 239000002562 thickening agent Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 claims 4
- 229920000858 Cyclodextrin Polymers 0.000 claims 4
- 150000002596 lactones Chemical class 0.000 claims 4
- 229960002957 praziquantel Drugs 0.000 claims 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 4
- CKVMAPHTVCTEMM-ALPQRHTBSA-N milbemycin oxime Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\2)O)C[C@H]4C1.C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\1)O)C[C@H]4C2 CKVMAPHTVCTEMM-ALPQRHTBSA-N 0.000 claims 3
- 229940099245 milbemycin oxime Drugs 0.000 claims 3
- 239000000230 xanthan gum Substances 0.000 claims 3
- 229920001285 xanthan gum Polymers 0.000 claims 3
- 235000010493 xanthan gum Nutrition 0.000 claims 3
- 229940082509 xanthan gum Drugs 0.000 claims 3
- 241000282472 Canis lupus familiaris Species 0.000 claims 2
- 241000282326 Felis catus Species 0.000 claims 2
- 239000003086 colorant Substances 0.000 claims 2
- 244000079386 endoparasite Species 0.000 claims 2
- 239000003906 humectant Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 claims 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims 1
- 239000005660 Abamectin Substances 0.000 claims 1
- 239000005894 Emamectin Substances 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 239000005918 Milbemectin Substances 0.000 claims 1
- 229950008167 abamectin Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 claims 1
- 229960003997 doramectin Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 claims 1
- WPNHOHPRXXCPRA-TVXIRPTOSA-N eprinomectin Chemical compound O1[C@@H](C)[C@@H](NC(C)=O)[C@H](OC)C[C@@H]1O[C@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C\C=C/[C@@H]2C)\C)O[C@H]1C WPNHOHPRXXCPRA-TVXIRPTOSA-N 0.000 claims 1
- 229960002346 eprinomectin Drugs 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 230000005484 gravity Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 229960002418 ivermectin Drugs 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 claims 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 claims 1
- 229960004816 moxidectin Drugs 0.000 claims 1
- YNFMRVVYUVPIAN-AQUURSMBSA-N nemadectin Chemical compound C1[C@H](O)[C@H](C)[C@@H](C(/C)=C/C(C)C)O[C@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YNFMRVVYUVPIAN-AQUURSMBSA-N 0.000 claims 1
- 229950009729 nemadectin Drugs 0.000 claims 1
- YNFMRVVYUVPIAN-UHFFFAOYSA-N nemadectin alpha Natural products C1C(O)C(C)C(C(C)=CC(C)C)OC11OC(CC=C(C)CC(C)C=CC=C2C3(C(C(=O)O4)C=C(C)C(O)C3OC2)O)CC4C1 YNFMRVVYUVPIAN-UHFFFAOYSA-N 0.000 claims 1
- -1 pH adjusters Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 150000003839 salts Chemical group 0.000 claims 1
- AFJYYKSVHJGXSN-KAJWKRCWSA-N selamectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(O[C@@H]([C@@H](C)CC2)C2CCCCC2)C2)C[C@@H]2OC(=O)[C@@H]([C@]23O)C=C(C)C(=N\O)/[C@H]3OC\C2=C/C=C/[C@@H]1C AFJYYKSVHJGXSN-KAJWKRCWSA-N 0.000 claims 1
- 229960002245 selamectin Drugs 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000006068 taste-masking agent Substances 0.000 claims 1
- 230000009974 thixotropic effect Effects 0.000 claims 1
- 239000000273 veterinary drug Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07120767 | 2007-11-15 | ||
| EP07120767.4 | 2007-11-15 | ||
| PCT/EP2008/065335 WO2009062939A1 (en) | 2007-11-15 | 2008-11-12 | Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011503140A JP2011503140A (ja) | 2011-01-27 |
| JP2011503140A5 true JP2011503140A5 (enExample) | 2012-01-05 |
| JP5319691B2 JP5319691B2 (ja) | 2013-10-16 |
Family
ID=39092818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010533558A Expired - Fee Related JP5319691B2 (ja) | 2007-11-15 | 2008-11-12 | プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100286154A1 (enExample) |
| EP (1) | EP2219643B1 (enExample) |
| JP (1) | JP5319691B2 (enExample) |
| AU (1) | AU2008322995B2 (enExample) |
| CA (1) | CA2703008A1 (enExample) |
| ES (1) | ES2385126T3 (enExample) |
| WO (1) | WO2009062939A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201041508A (en) * | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity |
| GB2482526A (en) * | 2010-08-05 | 2012-02-08 | Fiona Anne Macdonald | Praziquantel suspendable powder as an immersion fish treatment for parasites |
| EP2594258B1 (en) * | 2011-11-18 | 2020-03-18 | Veterinärmedizinische Universität Wien | Oral gel comprising praziquantel |
| WO2015064680A1 (ja) * | 2013-10-30 | 2015-05-07 | 大蔵製薬株式会社 | 服用し易いゼリー状医薬組成物 |
| GB2527555B (en) | 2014-06-25 | 2018-09-19 | Norbrook Lab Ltd | Stable methimazole liquid compositions |
| RU2613490C2 (ru) * | 2015-01-27 | 2017-03-16 | Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" | Композиция на основе R(-)-празиквантела для лечения и профилактики гельминтозов у теплокровных |
| JP7069119B2 (ja) | 2016-08-11 | 2022-05-17 | アダミス ファーマシューティカルズ コーポレーション | 医薬組成物 |
| EP3720844A4 (en) | 2017-12-08 | 2021-08-11 | Adamis Pharmaceuticals Corporation | MEDICINAL COMPOSITIONS |
| DE102018002904A1 (de) | 2018-04-09 | 2019-10-10 | Marc de Cocq | Die Verwendung von Praziquantel in Kombination mit Milbemycinen zur Behandlung von Fischen |
| CN109432440B (zh) * | 2018-11-30 | 2022-04-26 | 佛山科学技术学院 | 一种吡喹酮羟丙基环糊精包合物及其制备方法和应用 |
| RU2722272C1 (ru) * | 2019-04-30 | 2020-05-28 | Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" | Средство для лечения и профилактики нематодозов и цестодозов у мелких домашних животных |
| WO2022034226A1 (en) * | 2020-08-14 | 2022-02-17 | Universidad De Navarra | Avermectin and milbemycin compositions for inhalation |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447414A (en) * | 1982-12-21 | 1984-05-08 | Cutter Laboratories, Inc. | Carnivore anthelmintics |
| SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
| AUPM969994A0 (en) | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
| EP0959891A1 (en) * | 1996-07-30 | 1999-12-01 | Ashmont Holdings Limited | Anthelmintic formulations |
| GB9801109D0 (en) | 1998-01-20 | 1998-03-18 | Pfizer | Cyclodextrin compositions |
| US6207179B1 (en) | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
| US7704975B2 (en) * | 2000-12-19 | 2010-04-27 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
| KR20040104493A (ko) * | 2002-03-08 | 2004-12-10 | 바이엘 비지니스 서비시즈 게엠베하 | 구충용 아르테미시닌 유도체 (엔도퍼옥시드) |
| US20060205681A1 (en) * | 2002-06-21 | 2006-09-14 | Maryam Moaddeb | Homogenous paste formulations |
| US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
| US20040151759A1 (en) * | 2002-08-16 | 2004-08-05 | Douglas Cleverly | Non-animal product containing veterinary formulations |
| KR20070009671A (ko) * | 2004-05-06 | 2007-01-18 | 사이덱스 인크 | 세르트랄린 및 술포알킬 에테르 시클로덱스트린을 함유하는맛 마스킹된 제제 |
| MX2007000759A (es) * | 2004-07-22 | 2007-03-28 | Pfizer Prod Inc | Formulacion de enmascaramiento del sabor que comprende el farmaco en una forma de disolucion retardada y/o ciclodextrina en una forma de disolucion mejorada. |
| AU2007100254A4 (en) | 2007-03-29 | 2007-05-03 | Jurox Pty Ltd | Improved parasiticide paste |
-
2008
- 2008-11-12 CA CA2703008A patent/CA2703008A1/en not_active Abandoned
- 2008-11-12 US US12/742,257 patent/US20100286154A1/en not_active Abandoned
- 2008-11-12 JP JP2010533558A patent/JP5319691B2/ja not_active Expired - Fee Related
- 2008-11-12 EP EP08850197A patent/EP2219643B1/en not_active Not-in-force
- 2008-11-12 WO PCT/EP2008/065335 patent/WO2009062939A1/en not_active Ceased
- 2008-11-12 AU AU2008322995A patent/AU2008322995B2/en not_active Ceased
- 2008-11-12 ES ES08850197T patent/ES2385126T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011503140A5 (enExample) | ||
| ES2423505T3 (es) | Combinación antihelmíntica | |
| US6991801B2 (en) | Topical anthelmintic veterinary formulations | |
| CA2490309C (en) | Anthelmintic oral homogeneous veterinary pastes | |
| ES2743673T3 (es) | Composiciones parasiticidas orales veterinarias que comprenden agentes activos de acción sistémica, procedimientos y usos de las mismas | |
| FI3846786T3 (fi) | Maukkaat antiparasiittiset valmisteet | |
| ES2385126T3 (es) | Pasta antihelmíntica que comprende praziquantel, una lactona macrolida, ciclodextrina y un espesante | |
| US20040151759A1 (en) | Non-animal product containing veterinary formulations | |
| WO2007092620A3 (en) | Stable formulations, and methods of their preparation and use | |
| FI3370692T3 (fi) | Nenän tukkoisuutta poistava koostumus, jolla on antiviraalinen aktiivisuus | |
| HU230153B1 (hu) | Endo- és ektoparaziták elleni szer | |
| JP2019501108A5 (enExample) | ||
| TW200716202A (en) | Pediatric formulation of topiramate | |
| WO2011049713A3 (en) | Stabilized glucagon solutions | |
| FR2924024B1 (fr) | Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse | |
| ES2723779T3 (es) | Formulación para el control de piojos y garrapatas en el ganado | |
| WO2009064681A3 (en) | Liquid compositions comprising valsartan | |
| EP2455085A3 (en) | Use of at least one compound of the family of the avermectins or of the family of the milbemycins in the treatment of ophthalmic pathologies | |
| JP2012250937A (ja) | 歯磨組成物 | |
| JP2013500322A5 (enExample) | ||
| HRP20150306T1 (hr) | Upotreba nifuratela u lijeäśenju infekcija koje uzrokuju bakterije iz roda atopobium | |
| WO2011056871A3 (en) | Rhamnolipid mechanism | |
| DK1962598T3 (en) | Homogeneous paste formulations | |
| ES2527120T3 (es) | Composiciones no acuosas de bencimidazol | |
| JP2014504628A5 (enExample) |